Literature DB >> 11990246

Peripheral vascular diseases resulting from chronic arsenical poisoning.

Hsin-Su Yu1, Chih-Hung Lee, Gwo-Shing Chen.   

Abstract

Drinking water contaminated by arsenic remains a major public health problem. Long-term arsenic exposure has been found to be associated with peripheral vascular diseases in a variety of studies. Reports of vascular effects of arsenic in drinking water, which span almost 100 years, have been published in Taiwan, Chile, Mexico, and China. This paper reviewed the association of peripheral vascular diseases resulting from arsenic exposure to drinking water from the clinical and pathological points of view. An endemic peripheral vascular disorder called "blackfoot disease" has been noticed in a limited area in Taiwan. This disease results in gangrene in the extremities. It has been associated with the ingestion of high concentrations of arsenic-tainted artesian well water. Epidemiological studies confirmed a dose-response relationship between long-term arsenic exposure and the occurrence of blackfoot disease. Whereas arsenic has induced various clinical manifestations of vascular effects in Chile, Mexico and China, they do not compare in magnitude or severity to the blackfoot disease found in Taiwan. The pathogenesis of vascular effects induced by arsenic is still controversial. The possible mechanisms include endothelial cell destruction, arsenic-associated atherogenesis, carotene and zinc deficiency, and/or some immunological mechanism. Microcirculatory assessments revealed that deficits of capillary blood flow and permeability exist in clinically normal skin of patients with chronic arsenical poisoning. The vascular effects of chronic arsenic poisoning may involve cardiovascular and cerebrovascular systems as well. In view of the increasing public health problems caused by arsenic exposure, vascular effects should be included in the future study of health effects of arsenic.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11990246     DOI: 10.1111/j.1346-8138.2002.tb00234.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  10 in total

1.  Feedback inhibition by thiols outranks glutathione depletion: a luciferase-based screen reveals glutathione-deficient γ-ECS and glutathione synthetase mutants impaired in cadmium-induced sulfate assimilation.

Authors:  Timothy O Jobe; Dong-Yul Sung; Garo Akmakjian; Allis Pham; Elizabeth A Komives; David G Mendoza-Cózatl; Julian I Schroeder
Journal:  Plant J       Date:  2012-03-31       Impact factor: 6.417

2.  Neovascularization and angiogenic gene expression following chronic arsenic exposure in mice.

Authors:  Nicole V Soucy; Debra Mayka; Linda R Klei; Antonia A Nemec; John A Bauer; Aaron Barchowsky
Journal:  Cardiovasc Toxicol       Date:  2005       Impact factor: 3.231

3.  Aortic smooth muscle cell alterations in mice systemically exposed to arsenic.

Authors:  Shih-Chieh Chen; Shin-Yin Huang; Wen-Ting Lin; Rei-Cheng Yang; Hsin-Su Yu
Journal:  Heart Vessels       Date:  2015-07-02       Impact factor: 2.037

4.  Influence of GSTT1 Genetic Polymorphisms on Arsenic Metabolism.

Authors:  Molly L Kile; E Andres Houseman; Quazi Quamruzzaman; Mahmuder Rahman; Golam Mahiuddin; Golam Mostofa; Yu-Mei Hsueh; David C Christiani
Journal:  J Indian Soc Agric Stat       Date:  2013-08-01

5.  Aberrant cytokeratin expression during arsenic-induced acquired malignant phenotype in human HaCaT keratinocytes consistent with epidermal carcinogenesis.

Authors:  Yang Sun; Jingbo Pi; Xueqian Wang; Erik J Tokar; Jie Liu; Michael P Waalkes
Journal:  Toxicology       Date:  2009-06-12       Impact factor: 4.221

6.  A case of Bowen's disease and small-cell lung carcinoma: long-term consequences of chronic arsenic exposure in Chinese traditional medicine.

Authors:  Linda Lee; Gwyn Bebb
Journal:  Environ Health Perspect       Date:  2005-02       Impact factor: 9.031

Review 7.  Methylated Organic Metabolites of Arsenic and their Cardiovascular Toxicities.

Authors:  Ok-Nam Bae; Kyung-Min Lim; Ji-Yoon Noh; Keun-Young Kim; Eun-Kyung Lim; Jin-Ho Chung
Journal:  Toxicol Res       Date:  2008-09-01

Review 8.  Trace elements in hemodialysis patients: a systematic review and meta-analysis.

Authors:  Marcello Tonelli; Natasha Wiebe; Brenda Hemmelgarn; Scott Klarenbach; Catherine Field; Braden Manns; Ravi Thadhani; John Gill
Journal:  BMC Med       Date:  2009-05-19       Impact factor: 8.775

9.  Vascular dysfunction in patients with chronic arsenosis can be reversed by reduction of arsenic exposure.

Authors:  Jingbo Pi; Hiroshi Yamauchi; Guifan Sun; Takahiko Yoshida; Hiroyuki Aikawa; Wataru Fujimoto; Hiroyasu Iso; Renzhe Cui; Michael P Waalkes; Yoshito Kumagai
Journal:  Environ Health Perspect       Date:  2005-03       Impact factor: 9.031

10.  Gallic acid and MiADMSA reversed arsenic induced oxidative/nitrosative damage in rat red blood cells.

Authors:  Archna Panghal; Kshirod Bihari Sathua; S J S Flora
Journal:  Heliyon       Date:  2020-02-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.